F605 in Connecticut. Pick another state for the same tag.
Against expectation — 2025
Connecticut cites F605 less often than its own record predicts
Versus expected share0.09×
0.09 times the national share — cited less often here than elsewhere.
Share of Connecticut citations0.06%
Of every deficiency written in Connecticut in 2025, this is the portion that was F605.
Connecticut0.06%
National0.71%
Share of all citations that were F605.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Connecticut surveyors wrote
F605 findings written in Connecticut, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
J · Immediate jeopardy, isolatedJune 23, 2026
Based on record review, facility documentation review, observation of facility video, and staff interviews for one of three residents (Resident #1), reviewed for accidents, the facility failed to ensure a resident with dementia that was dependent for personal care and mobility and had no physician orders for opioids was free from exposure to opioids. The resident was identified unresponsive to verbal or tactile stimulation with pinpoint pupils, and was transferred to the hospital where he/she was diagnosed with suspected opioid intoxication, received Narcan, and had two (2) laboratory tests that were positive for opioids, resulting in a finding of Jeopardy. …
D · No harm, potential for more than minimal, isolatedJuly 29, 2026
Based on observation, review of the clinical record, facility policy and interviews for 1 of 5 sampled residents (Resident #10) reviewed for unnecessary medications for antipsychotic use, the facility failed to attempt a Gradual Dose Reduction (GDR), document a past unsuccessful attempt of a GDR, failed to document target behaviors when the antipsychotic was used for agitation, and failed to document any non-pharmacological approaches used in an attempt to facilitate the reduction of psychotropic medication. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction